Pennsylvania Cancer Specialists Research Institute — Gettysburg, Pennsylvania

Pennsylvania Cancer Specialists Research Institute is a clinical research site located in Gettysburg, Pennsylvania, United States 17325.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Pennsylvania Cancer Specialists Research Institute has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Non Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Melanoma.

Sponsors: OncoC4, Inc., FutureChem, Endocyte.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gettysburg

Browse all research sites in Pennsylvania · View every site in Gettysburg

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pennsylvania Cancer Specialists Research Institute?

Pennsylvania Cancer Specialists Research Institute has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pennsylvania Cancer Specialists Research Institute conducted?

Pennsylvania Cancer Specialists Research Institute has 7 clinical trials on record, with 3 currently active. Their work covers Non Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Melanoma.

Is Pennsylvania Cancer Specialists Research Institute accredited by Crixeo Clinical Trials?

Pennsylvania Cancer Specialists Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pennsylvania Cancer Specialists Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.